Whole-exome or whole-genome sequencing is becoming routine in clinical situations for identifying mutations underlying presumed genetic causes of disease including infertility. While this is a powerful approach for implicating polymorphisms or de novo mutations in genes plausibly related to the phenotype, a greater challenge is to definitively prove causality. This is a crucial requisite for treatment, especially for infertility, in which validation options are limited. In this study, we created a mouse model of a putative infertility allele, DMC1 M200V . DMC1 encodes a RecA homolog essential for meiotic recombination and fertility in mice. This allele was originally implicated as being responsible for the sterility of a homozygous African woman, a conclusion supported by subsequent biochemical analyses of the mutant protein and by studies of yeast with the orthologous amino acid change. Here, we found that Dmc1 M200V/M200V male and female mice are fully fertile and do not exhibit any gonadal abnormalities. Detailed immunocytological analysis of meiosis revealed no defects suggestive of compromised fertility. This study serves as a cautionary tale for making conclusions about consequences of genetic variants, especially with respect to infertility, and emphasizes the importance of conducting relevant biological assays for making accurate diagnoses in the era of genomic medicine.
Introduction
Surveys estimate that 10-15% of the United States population experiences some form of infertility (1) , and it is believed that as many as half of infertility cases have an underlying genetic basis. Over the past decade, candidate gene sequencing and wholeexome/genome re-sequencing have become increasingly used clinically for identifying potential causes of presumed genetic disorders including infertility. Several studies have employed the general approach of identifying a candidate variant/mutation in a sterile patient(s), sequencing the suspect gene in a number of normal patients, and then suggesting causation of the candidate mutation if it is unique (or homozygous in) only the infertile people (2) (3) (4) (5) . However, such correlation is not proof, as illustrated in the case of a purported globozoospermia allele of Spata16 (6) that was shown by mouse modeling to not impact fertility (7) .
A major strategy for identifying and implicating putative disease mutations is the use of algorithms designed to predict the impact of mutations on protein function. Popular algorithms such as Polyphen-2, SIFT and FATHMM utilize direct or machinelearning strategies to assess protein sequence, structure and amino acid properties to generate predictions (8) (9) (10) . Nonetheless, recent work has found that the predictions of damaging alleles are frequently inaccurate, and many predicted null mutations cause subtle deficiencies at best (11, 12) . In addition, studies specifically aimed at fertility effects in vivo found that as low as 25% of predicted high-damaging variants cause any detectable phenotype (13) . Although computational approaches can be useful, these studies emphasize that current algorithms may not be sufficiently reliable for high-confidence assessment of the physiological impact of variants, especially in a clinical context.
In this present study, we took a closer look at a variant of human DMC1, a methionine-to-valine change at amino acid position 200 (Dmc1 M200V ). Dmc1 is a meiosis-specific homolog of Escherichia coli RecA and is essential for the repair of SPO11/TOP6BL-induced double-strand breaks (DSBs) by homologous recombination (14) (15) (16) (17) , a process that is essential for pairing of chromosome homologs. Dmc1 knockout mice are sterile due to arrest of meiocytes stemming from failed homologous chromosome synapsis (14, 18) and activation of the meiotic DNA damage checkpoint (19) . DMC1 M200V was implicated as being responsible for premature ovarian failure in an African woman who was homozygous for this allele (20, 21 
Results

Dmc1
M200V/M200V mice are fertile and phenotypically similar to wild type To generate mice modeling the human DMC1 M200V allele, CRISPR/Cas9-mediated genome editing in single-celled zygotes was performed. As diagrammed in Figure 1A and B, a singlestranded oligodeoxynucleotide (ssODN) was used as a template to introduce two nucleotide changes into codon 200 via homologous recombination, causing this codon to encode valine instead of methionine. Founder mice with the desired mutation were identified (Fig. 1C) testis weights and sperm counts were indistinguishable from WT ( Fig. 2B, C) . Similarly, mutant testis histology revealed no abnormalities in spermatogenesis (Fig. 2D) . Although females had normal fecundity, it is possible that the mutation caused reduction in the ovarian reserve. Because DMC1 is required for DSB repair, any deficiency in its function would result in activation of the DNA damage checkpoint, eliminating oocytes perinatally before folliculogenesis (19, 22) . WT and Dmc1 M200V/M200V ovaries were histologically indistinguishable (Fig. 2E) . We serially sectioned mutant and WT ovaries and quantified the total number of primordial follicles in 3-week-old ovaries, revealing no significant difference (Fig. 2F) . These results are consistent with the breeding studies and provide no evidence of any compromise to gametogenesis in either sex.
DMC1
M200V does not disrupt meiotic chromosome behavior in mice
Despite having normal fertility, fecundity and histology, it is possible that the M200V amino acid change has a mild effect only detectable at the cellular level. Dmc1 is a meiosis-specific recombinase that acts at sites of meiotically programmed DSBs to catalyze D-loop formation and strand exchange between chromosomes, ultimately promoting chromosome pairing, synapsis and recombination (14, 15, 18, 23 to sites of meiotic DSBs, catalyzes homologous recombination repair of these DSBs which is essential for pairing of homologous chromosomes and is properly released from processed DSBs following repair. Next, we immunolabeled spreads with γ H2AX, a histone variant phosphorylated at sites of DNA damage, which also serves as a marker of the transcriptionally silenced and heterochromatinized XY body that forms in pachynema (25) . Similar to WT, leptotene and zygotene Dmc1
M200V/M200V
spermatocytes had high levels of γ H2AX along chromosomes (data not shown) and by pachynema, γ H2AX was exclusive to the X and Y chromosomes, indicative of complete DSB repair on autosomes and XY body formation (Fig. 3C ). We then immunolabeled chromosome spreads for SYCP3 and the transverse element protein SYCP1, which marks regions of complete synapsis between homologs (24). In the absence of DMC1, repair of meiotic DSBs does not occur, and homologous chromosomes do not synapse (14, 18) . SC formation occurred normally in Dmc1 M200V/M200V spermatocytes as indicated by SYCP3/SYCP1 staining of pachytene chromosomes (Fig. 3D ). This indicates that DMC1 M200V does not affect homologous chromosome synapsis. Meiotic DSBs are repaired by one of two mechanisms: the majority (∼90%) as non-crossovers (NCOs) and the rest as crossovers (COs). While both types of events are important for driving homolog pairing and synapsis, chiasmata formed by CO events are essential for proper chromosome segregation at the first meiotic division. They ensure that homologs correctly align at the metaphase plate and segregate to opposite poles when the COs are resolved. To test whether CO formation is affected in Dmc1 M200V/M200V mutants, we quantified MLH1
foci-a proxy for the predominant class of COs in mice-in pachytene spermatocyte nuclei (Fig. 3E) . Interestingly, whereas WT spermatocytes had 23 ± 2.0 MLH1 foci/cell (average ± SEM, n = 3, 96 cells), Dmc1 M200V/M200V had 22 ± 2.4 MLH1 foci/cell (average ± SEM, n = 4, 120 cells), which is a small but statistically significant difference (P-value = 0.03; Fig. 3F ).
One copy of Dmc1 M200V is sufficient for normal meiosis
Although fertility, fecundity and meiotic prophase I chromosome behavior was normal in Dmc1 M200V/M200V mice, we considered the possibility that the mutant protein might be compromised in a subtle way that would only manifest under more challenging conditions. Accordingly, we bred mice hemizygous for Dmc1 M200V (Dmc1 M200V/-) by crossing our
Dmc1
M200V/M200V to mice heterozygous for a functional Dmc1 allele (Dmc1 tm1Jcs ). The testis weights and sperm counts of 8-weekold Dmc1 M200V/-males were no different than WT (Fig. 4A, B) , and testis histology was unremarkable (Fig. 4C) . Likewise, females at 3 weeks of age had primordial follicle counts similar to WT (Fig. 4D) . Lastly, breeding Dmc1 M200V/-animals to WT mates yielded normal sized litters; males sired an average of 8.8 pups/litter and females birthed 8.8 pups/litter (P-value = 0.55
and P-value = 0.90, respectively; Fig. 2A ). These results provide further evidence that under in vivo conditions, DMC1 M200V has no substantial impact on fertility, fecundity or gametogenesis.
Discussion
Remarkable advances in genomics capabilities in the past few years are revolutionizing medicine. As DNA sequencing costs have dropped precipitously, it is becoming more routine to use whole-exome or whole-genome sequencing as clinical tests for certain common (namely, cancer) or rare diseases (such as undiagnosed developmental disorders). This will certainly become more commonplace for identifying potential genetic causes of idiopathic infertility in individual patients. Coupled with the advent of genome editing technology, it is increasingly plausible (scientifically) to envision genetic correction of infertility-causing alleles, particularly in males where spermatogonial stem cells are present and can be cultured, manipulated and returned into the patient. Of course such interventions, should they indeed be deemed as safe and acceptable, are absolutely dependent upon unequivocal identification of the infertility-causing mutation or variant. The work presented here is part of an NIH-funded project (see acknowledgements) we have undertaken to specifically address this issue (13) , and our results serve to highlight the serious nature of the problem. The Dmc1 M200V allele was identified as a potentially causative infertility variant 10 years ago (20,21) and associated work provided compelling evidence that the allele encoded a protein with altered biochemical activities that might be consistent with disrupted meiosis (21) . However, our in vivo modeling of this allele showed that this allele, in mice, did not impact fertility or fecundity at all. While we are of the opinion that in vivo modeling in mice is a more physiologically relevant biological test than in vitro biochemical assays, there are still potential caveats. One is that it is possible that the M200V alteration is tolerated in mice but not humans. We consider this unlikely because the mouse and human DMC1 proteins are 97.5% identical, and there are no differences from position M200 to the C terminus of both proteins (position 340). The nearest difference is conservative (ASP versus GLU), 18 AAs N terminal. Nevertheless, we checked the octameric ring crystal structure (21) to see if M200 interacts with a polymorphic distant residue in the folded state. The Met200 residue on helix alpha-11 of one DMC1 monomer appears to interact with MET249 on alpha helix 13 of the adjacent DMC1 monomer. This amino acid, as well as the entire AA sequence of both alpha helices are identical between mouse and human. Finally, there are no Dmc1 paralogs unique to mice, and the mouse gene is absolutely required for meiosis and fertility in mice.
It is also conceivable that the gonadal environment in humans is such that the M200V change is catalytically more unstable in human meiocytes than in mouse meiocytes. For example, we found that in Dmc1 M200V/M200V spermatocytes, there was a slight decrease (<5%) in the number of MLH1 foci. However, the number of MLH1 foci varies among inbred strains (26) , and since the founder mice were of mixed genetic background, it is possible that the variation is due to these differences, possibly linked to the Dmc1 locus. Nevertheless, the impact, if any, was negligible in terms of all other reproductive parameters (e.g. germ cell numbers, litter sizes etc.). A final caveat is the possibility that the mixed genetic background used in this study somehow suppressed the biochemical consequences of the Dmc1 M200V mutation, and that if placed in other backgrounds (say, a completely inbred background), that a hypomorphic phenotype might be revealed. However, there have been no reports of anything but catastrophic germ cell loss in Dmc1 null mouse studies (14, 18) in numerous laboratories (including our own, where we produced the first null allele, and have maintained it in the C57BL/6J background). The case of Dmc1 M200V is emblematic of the challenges facing genetic diagnosis of infertility in a clinical situation. Computational algorithms are useful for estimating the potential damage of a variant on protein function, but should not serve as an endpoint during the validation process due to their insufficient reliability (11, 12) , particularly if the information was to be used for treatment actions. The DMC1 M200V allele was originally cited as being 'probably damaging' by the widely used Polyphen algorithm (20) . However, the updated Polyphen-2 now predicts the variant as benign, as does FATHMM, SNPs & GO and SIFT. In contrast, PANTHER and Mutation Assessor score the allele as being 'possibly damaging' and 'medium functional impact', respectively. Current algorithms measure different criteria with different emphases, which can result in contradictory conclusions. However, technology is dynamic, and with increasing numbers of in vivo studies and training data sets, these algorithms may become more accurate with time. Another indicator of whether an allele might cause infertility is allele frequency. As noted by He et al. (27) , the Dmc1 M200V has a high allelic frequency in African populations (12% according to the gnomAD database), which seems incompatible with it being an infertility allele.
In conclusion, this study highlights the importance of in vivo modeling to make accurate conclusions about putative infertility-associated polymorphisms or de novo mutations before taking clinical actions. While mice are currently the most accurate models for this (7, 13, 28) , we anticipate that improvements to in vitro gametogenesis, especially with human cells, will be important for development of higher-throughput and lower-cost analysis for diagnostics of genetic causes of human infertility.
Materials and Methods
Generation of Dmc1 M200V mice by CRISPR-Cas9 genome editing
An optimal guide sequence was selected using online software at mit.crispr.edu. The crRNA and CRISPR-Cas9 tracrRNA was synthesized by IDT (ALT-R service) and the ssODN was also synthesized by IDT's (Ultramer service). Prior to pronuclear injection, the crRNA (25 ng/μl) and tracrRNA (25 ng/μl) were co-incubated to form a ribonucleoprotein complex according to manufacturer's instructions. The ssODN (50 ng/μl) and additional CAS9 Figure 2 were Dmc1 M200V/-(n = 4; 54 300 000 ± 703 562) and Dmc1 +/-(n = 2; average ± SEM = 56 100 000 ± 600 000). P-values were from the Student's t-test. (C) Representative image of paraffin-embedded and H&E stained testis cross-section from an 8-week-old Dmc1 M200V/-male. Size bar, 75 μm. (D) Primordial follicle counts from three-week old Dmc1 M200V/-ovaries. The chart includes some data from Figure 2F . The average ± SEM for Dmc1 M200V/-was 2 416 ± 155 follicles/ovary (n = 3 animals and 6 ovaries).
protein (1000 ng/μl; PNA Bio) were added, and all materials were co-injected into zygotes (F1 hybrids between strains FVB/NJ and B6(Cg)-Tyr c-2J /J), then transferred into the oviduct of pseudopregnant females. Founders bearing at least one copy of the desired alteration were identified by PCR with primers flanking the SNP (Supplementary Material, Table I ), then backcrossed into FVB/NJ. Initial phenotyping was performed after one backcross generation followed by intercrossing, then additional phenotyping was done with animals backcrossed additional two or more generations. No phenotypic differences were found among different generations. All sequences used for CRISPR-Cas9 editing and mouse genotyping are in Supplementary Material, Table I .
Mice
The Dmc1 tm1Jcs allele (referred to in the text as Dmc1 -) was previously described (18) . All animal use was conducted under protocol (2004-0038) to J.C.S. and approved by Cornell University's Institutional Animal Use and Care Committee.
Genotyping of Dmc1
M200V and Dmc1 +/-mice Toes or ear clips were collected from pups at 8-14 days of age. A crude DNA lysate was made as described (29) . PCR was performed using EconoTaq and associated reagents (Lucigen), following the manufacturer's protocol with 3 μl of crude DNA lysate per reaction. Primers were obtained from IDT and sequences are listed in Supplementary Material, 
Histology and primordial follicle quantification
Testes were harvested from 8-week-old males and fixed in Bouin's for 24 h, washed in 70% ethanol for 24 h and embedded in paraffin. Sections of 6 μm were made and stained with hematoxylin and eosin (H&E). Ovaries were harvested from 3-week-old females and prepared in the same way, then serial sectioned at 6 μm. Primordial follicles were counted in every fifth section and final follicle counts were calculated as previously described (30) . Statistical analysis was done with a two-tailed Student's t-test on Prism 7 (GraphPad).
Sperm counts
Epidydymides were isolated from 8-week-old males. The tissue was minced in 5 ml of MEM media and incubated at 37
• C for 15 min, allowing spermatozoa to swim out. The spermatozoa were diluted 1:2 in MEM and counted using a hemacytometer
Immunocytochemistry of meiotic chromosomes
We used a published protocol (31) . In brief, testes were isolated from 8-to 12-week-old males, detunicated and minced in MEM media. Spermatocytes were hypotonically swollen in 4.5% sucrose solution, lysed in 0.1% Triton X-100, 0.02% SDS and 2% formalin. Slides were washed and stained immediately or stored at -80 • C. Blocking buffer used was 5% goat serum in PBS, 0.1% Tween20 and slides were blocked for 1 h at room temperature. Primary antibodies and dilutions used were anti-SYCP3 (1:600, Abcam, #ab15093), anti-SYCP3 (1:600, Abcam, #ab97672), anti-SYCP1 (1:400, Abcam, #ab15090), anti-DMC1 (1:100, Abcam, #ab11054), anti-MLH1 (1:100, BD Pharmingen, #554073) and antiphospho-H2A.X (1:1000, Millipore, #16-193). Primary staining of chromosome surface spreads was done at 37
• C and incubated overnight. Secondary antibodies used were goat anti-mouse IgG AlexaFluor 488 (1:1000, ThermoFisher Scientific, #R37120) and goat anti-rabbit IgG AlexaFluor 594 (1:800, ThermoFisher Scientific, #R37117). Secondary antibodies were incubated for 1 h at room temperature. Images were acquired with an Olympus microscope with 40x lens using cellSens software (Olympus). Foci were quantified using ImageJ with plugins Cell Counter (Kurt De Vos) and Nucleus Counter. All data were analyzed in Prism 7 (GraphPad).
Supplementary Material
Supplementary Material is available at HMG online.
